Exercise Triggers Liver Enzyme to Repair Aging Blood-Brain Barrier and Boost Memory

UCSF researchers find that a liver enzyme triggered by exercise repairs the blood-brain barrier. Learn how this discovery could lead to new Alzheimer’s treatments.

By: AXL Media

Published: Feb 21, 2026, 4:34 AM EST

Source: Information for this report was sourced from University of California - San Francisco - https://www.ucsf.edu/

The Body-to-Brain Connection in Cognitive Health

For years, the cognitive benefits of physical activity were well-documented but poorly understood at a molecular level. Researchers at the UCSF Bakar Aging Research Institute have now mapped a specific biological circuit that begins in the liver and ends in the brain's protective shielding. The study, published in the journal Cell, reveals that exercise induces the liver to secrete an enzyme called GPLD1. This enzyme acts as a systemic repair agent, traveling through the bloodstream to maintain the integrity of the brain’s vascular defenses.

Restoring the Blood-Brain Barrier’s Protective Shield

The blood-brain barrier (BBB) is a sophisticated network of tightly packed cells designed to keep toxins out of sensitive brain tissue. As organisms age, this barrier becomes increasingly permeable, or "leaky," allowing damaging inflammatory compounds to seep into the brain. The UCSF team identified that a protein called TNAP accumulates on the surface of these barrier cells over time, weakening their structure. When the liver-derived enzyme GPLD1 reaches these vessels, it effectively "trims" away the excess TNAP, restoring the barrier's seal and preventing neurotoxic infiltration.

TRANSFORMATIVE ANALYSIS: This research represents a fundamental shift in Alzheimer’s strategy, moving from a "brain-centric" view to a "systemic" view of neurodegeneration. While traditional therapies focus on clearing plaques already inside the brain, this discovery suggests that reinforcing the "fortress walls" (the BBB) from the outside may be more effective. From a drug-development perspective, targeting an enzyme in the liver or bloodstream is significantly easier than designing molecules that must cross the difficult-to-penetrate blood-brain barrier, potentially lowering the technical bar for future dementia medications.

Evidence of Cognitive Reversal in Aging Models